| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Apixaban |
| Brand | Eliquis® |
| Indication | For treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults. |
| Assessment Process | |
| Rapid review commissioned | 29/07/2014 |
| Rapid review completed | 10/08/2014 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation not Recommended |